Cargando…

JMJD8 Promotes Malignant Progression of Lung Cancer by Maintaining EGFR Stability and EGFR/PI3K/AKT Pathway Activation

JMJD8 is a JmjC domain-containing protein that has not been widely examined, despite its potential role in malignant tumor development. The underlying biological functions and molecular mechanisms of JMJD8 in non-small-cell lung cancer (NSCLC) remain unclear. Herein, we explored the relationship bet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Bo, Zhang, Yao, Jiang, Xizi, Su, Hongbo, Wang, Qiongzi, Wudu, Muli, Jiang, Jun, Ren, Hongjiu, Xu, Yitong, Liu, Zongang, Qiu, Xueshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2021
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7797639/ https://www.ncbi.nlm.nih.gov/pubmed/33442397 http://dx.doi.org/10.7150/jca.50234

Ejemplares similares

MKRN2 inhibits migration and invasion of non-small-cell lung cancer by negatively regulating the PI3K/Akt pathway
por: Jiang, Jun, et al.
Publicado: (2018)

TRIM67 Promotes the Proliferation, Migration, and Invasion of Non-Small-Cell Lung Cancer by Positively Regulating the Notch Pathway
por: Jiang, Jun, et al.
Publicado: (2020)

TBC1 domain family member 23 interacts with Ras‐related protein Rab‐11A to promote poor prognosis of non‐small‐cell lung cancer via β1‐integrin
por: Zhang, Yao, et al.
Publicado: (2021)

KLHL18 inhibits the proliferation, migration, and invasion of non-small cell lung cancer by inhibiting PI3K/PD-L1 axis activity
por: Jiang, Xizi, et al.
Publicado: (2020)

DRAM2 acts as an oncogene in non-small cell lung cancer and suppresses the expression of p53
por: Wudu, Muli, et al.
Publicado: (2019)

KIAA0247 inhibits growth, migration, invasion of non‐small‐cell lung cancer through regulating the Notch pathway
por: Xu, Yitong, et al.
Publicado: (2018)

MZT2A promotes NSCLC viability and invasion by increasing Akt phosphorylation via the MOZART2 domain
por: Wang, Huanxi, et al.
Publicado: (2021)

Silencing of CASC8 inhibits non-small cell lung cancer cells function and promotes sensitivity to osimertinib via FOXM1
por: Jiang, Xizi, et al.
Publicado: (2021)

KLHL38 involvement in non-small cell lung cancer progression via activation of the Akt signaling pathway
por: Xu, Yitong, et al.
Publicado: (2021)

CBLL1 is highly expressed in non‐small cell lung cancer and promotes cell proliferation and invasion
por: Hui, Linping, et al.
Publicado: (2019)

E3 ubiquitin ligase tripartite motif-containing 71 promotes the proliferation of non-small cell lung cancer through the inhibitor of kappaB-α/nuclear factor kappaB pathway
por: Ren, Hongjiu, et al.
Publicado: (2017)

JMJD5 inhibits lung cancer progression by facilitating EGFR proteasomal degradation
por: Shen, Jing, et al.
Publicado: (2023)

Fangchinoline exerts antitumour activity by suppressing the EGFR-PI3K/AKT signalling pathway in colon adenocarcinoma
por: Jiang, Fengqi, et al.
Publicado: (2021)

Dissecting the EGFR-PI3K-AKT pathway in oral cancer highlights the role of the EGFR variant III and its clinical relevance
por: Chang, Kwang-Yu, et al.
Publicado: (2013)

[6]-Paradol suppresses proliferation and metastases of pancreatic cancer by decreasing EGFR and inactivating PI3K/AKT signaling
por: Jiang, Xueyi, et al.
Publicado: (2021)

Targeting EGFR/PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma
por: Bang, Jieun, et al.
Publicado: (2023)

SCD1 is required for EGFR-targeting cancer therapy of lung cancer via re-activation of EGFR/PI3K/AKT signals
por: She, Kelin, et al.
Publicado: (2019)

FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR
por: Li, Lei, et al.
Publicado: (2019)

SKA3 promotes lung adenocarcinoma metastasis through the EGFR–PI3K–Akt axis
por: Hu, Dan-dan, et al.
Publicado: (2020)

GE11 peptide conjugated selenium nanoparticles for EGFR targeted oridonin delivery to achieve enhanced anticancer efficacy by inhibiting EGFR-mediated PI3K/AKT and Ras/Raf/MEK/ERK pathways
por: Pi, Jiang, et al.
Publicado: (2017)

Fibulin7 Mediated Pathological Cardiac Remodeling through EGFR Binding and EGFR‐Dependent FAK/AKT Signaling Activation
por: Zheng, Xuehui, et al.
Publicado: (2023)

PI3K-AKT-mTOR pathway alterations in advanced NSCLC patients after progression on EGFR-TKI and clinical response to EGFR-TKI plus everolimus combination therapy
por: Fang, Wenfeng, et al.
Publicado: (2020)

TUC338 Promotes Diffuse Large B Cell Lymphoma Growth via Regulating EGFR/PI3K/AKT Signaling Pathway
por: Li, Yan, et al.
Publicado: (2021)

JMJD8 Functions as a Novel AKT1 Lysine Demethylase
por: Wang, Yujuan, et al.
Publicado: (2022)

Exosomes transmit T790M mutation‐induced resistance in EGFR‐mutant NSCLC by activating PI3K/AKT signalling pathway
por: Liu, Xiaozhen, et al.
Publicado: (2020)

Clonorchis sinensis Granulin Promotes Malignant Transformation of Hepatocyte Through EGFR-Mediated RAS/MAPK/ERK and PI3K/Akt Signaling Pathways
por: Wang, Caiqin, et al.
Publicado: (2021)

Targeting TF-AKT/ERK-EGFR Pathway Suppresses the Growth of Hepatocellular Carcinoma
por: Huang, Shan-Zhou, et al.
Publicado: (2019)

Bufalin Reverses HGF-Induced Resistance to EGFR-TKIs in EGFR Mutant Lung Cancer Cells via Blockage of Met/PI3k/Akt Pathway and Induction of Apoptosis
por: Kang, Xiao-Hong, et al.
Publicado: (2013)

Protein Tyrosine Kinase 7 Regulates EGFR/Akt Signaling Pathway and Correlates With Malignant Progression in Triple-Negative Breast Cancer
por: Cui, Nai-Peng, et al.
Publicado: (2021)

SGCE Promotes Breast Cancer Stem Cells by Stabilizing EGFR
por: Zhao, Lina, et al.
Publicado: (2020)

Metapristone (RU486 metabolite) suppresses NSCLC by targeting EGFR-mediated PI3K/AKT pathway
por: Shao, Jingwei, et al.
Publicado: (2017)

CAV2 promotes the growth of renal cell carcinoma through the EGFR/PI3K/Akt pathway
por: Liu, Fu, et al.
Publicado: (2018)

In Vitro Evaluation of the Neuroprotective Effect of Panax notoginseng Saponins by Activating the EGFR/PI3K/AKT Pathway
por: Wu, Shuang, et al.
Publicado: (2020)

CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway
por: Li, Linjin, et al.
Publicado: (2022)

Differential Regulation of the EGFR/PI3K/AKT/PTEN Pathway between Low- and High-Grade Gliomas
por: Erira, Alveiro, et al.
Publicado: (2021)

Dracohodin Perochlorate Stimulates Fibroblast Proliferation via EGFR Activation and Downstream ERK/CREB and PI3K/Akt/mTOR Pathways In Vitro
por: Liu, Lin, et al.
Publicado: (2019)

EGFR-AS1 Promotes Bladder Cancer Progression by Upregulating EGFR
por: Wang, Anbang, et al.
Publicado: (2020)

Claudin-3 Overexpression Increases the Malignant Potential of Colorectal Cancer Cells: Roles of ERK1/2 and PI3K-Akt as Modulators of EGFR signaling
por: de Souza, Waldemir F., et al.
Publicado: (2013)

MicroRNA-1231 exerts a tumor suppressor role through regulating the EGFR/PI3K/AKT axis in glioma
por: Zhang, Jiale, et al.
Publicado: (2018)

PSMC4 promotes prostate carcinoma progression by regulating the CBX3–EGFR‐PI3K‐AKT‐mTOR pathway
por: Liu, Kaifeng, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_015m00b1s15vu1bdtjk4701alo